Logistics operators in the healthcare sector are rapidly expanding temperature-controlled distribution networks to accommodate unprecedented volume growth in GLP-1 receptor agonist medications.
Cold-Chain Infrastructure Bottlenecks
Maintaining strict 2 to 8 degrees Celsius transport environments across global trade routes requires expanded refrigerated air-freight capacity and specialized fulfillment hubs. Inadequate cold-chain capacity risks localized supply shortages.
Strategic Investments in Contract Manufacturing
Pharmaceutical companies are contracting third-party fill-finish facility operators to scale packaging output. Specialized biopharma logistics capital investments are projected to increase substantially over the next three fiscal years.